J&J Proposes Actelion Takeover Worth Billions

Nov 26, 2016

Johnson & Johnson says it is in negotiations with Actelion Ltd. about a possible takeover of the $19.9 billion Swiss biotech company.

Actelion and J&J confirmed the talks in separate statements Friday, saying there was no guarantee a deal will happen. Actelion is working with an adviser to discuss options, according to a Bloomberg article, and the deliberations are still at an early stage following Johnson & Johnson’s initial offer, according to sources close to the matter.

The company may also attract other suitors, such as Novartis AG and Sanofi, other sources said.

Read the Bloomberg story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments